approval
saveERLEADA (APALUTAMIDE) — FDA approval
community read0 votes
Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalERLEADA (APALUTAMIDE) — FDA approvalMar 5, 2026 · 213d ago
- approvalERLEADA (APALUTAMIDE) — FDA approvalAug 2, 2024 · 793d ago
- approvalERLEADA (APALUTAMIDE) — FDA approvalJul 9, 2024 · 817d ago
- approvalERLEADA (APALUTAMIDE) — FDA approvalFeb 17, 2023 · 1325d ago
- approvalERLEADA (APALUTAMIDE) — FDA approvalNov 8, 2022 · 1426d ago
- approvalERLEADA (APALUTAMIDE) — FDA approvalNov 8, 2022 · 1426d ago
- approvalERLEADA (APALUTAMIDE) — FDA approvalApr 26, 2022 · 1622d ago
- approvalERLEADA (APALUTAMIDE) — FDA approvalSep 7, 2021 · 1853d ago
same company · ±60 days · 6
- approvalerdafitinib: BALVERSA (ERDAFITINIB) — FDA approvalJan 19, 2024
- approvalerdafitinib: BALVERSA (ERDAFITINIB) — FDA approvalJan 19, 2024
- approvalerdafitinib: BALVERSA (ERDAFITINIB) — FDA approvalJan 19, 2024
- approvalSIMPONI (GOLIMUMAB) — FDA approvalNov 16, 2023
- approvaltalquetamab: TALVEY (TALQUETAMAB-TGVS) — FDA approvalNov 16, 2023
- approvalteclistamab: TECVAYLI (TECLISTAMAB-CQYV) — FDA approvalNov 16, 2023
comments(0)
5-min edit window · permanent after that